This timely new treatise fills a crucial information need for patent practitioners by focusing on the many significant changes to patent law that uniquely affect the vast pharmaceutical and biotechnology industries and on how Congress and the courts are responding to the subsequent growth in patent litigation.Organized to present patent law issues that arise from the earliest stages of drug discovery through final regulatory approval and marketing, Pharmaceutical and Biotech Patent Law features the expert contributions of attorneys of the Patent Group of Kaye Scholer LLP